MGNX (MacroGenics Inc.) Net earnings per share growth this year

MGNX (MacroGenics Inc.) - company brandmark

MacroGenics, Inc. (MGNX) operates a non-cyclical business in the oncology sector, where demand for breast cancer therapy ignores macroeconomic trends. The relative annual earnings per share growth metric on GURU.Markets confirms a dependence on drug approvals, with the indicator reaching -36.70. The company's stability amid external shocks and its outsourcing of production to third-party contractors create a solid foundation for future growth.

Earnings per share growth in current year: MacroGenics Inc (MGNX) for 07/04/2022 - 11/14/2026

Financial and market metric breakdowns for MacroGenics, Inc. (MGNX)

- stock quotes and analyst forecast:
Share Price MacroGenics Inc|MGNX - Analyst Consensus Forecast
- business market valuation indicators:
Market Valuation MacroGenics Inc.|MGNX - Enterprise Value
- company book value details:
Net Asset Value per Share MacroGenics|MGNX - Company Book Value|Market Value to Book Value macrogenics.com|MGNX - Aggregate Company Assets
- debt burden and liquidity indicators:
Total Debt to Equity Ratio MacroGenics, Inc.|MGNX - Long-Term Debt to Capital|Short-Term Debt to Capital macrogenics.com|MGNX - Company Aggregate Debts|Debt to Book Value MacroGenics Inc.|MGNX - Company Long-Term Debt|Company Short-Term Loans and Borrowings MacroGenics|Immediate Liquidity macrogenics.com
- company profitability and valuation multiples indicators:
MGNX - Net Profit|Projected Net Profit MacroGenics, Inc.|MGNX - P/E Multiple|Projected Price to Earnings Ratio MacroGenics Inc.|MGNX - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation MacroGenics Inc.|MGNX - Operating profit EBITDA|Net earnings per share for the last four quarters MacroGenics|MGNX - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months macrogenics.com|MGNX - Earnings per share growth in current year|Consensus forecast of earnings per share growth for next year MacroGenics, Inc.
- revenue and sales proceeds data:
MGNX - Company Sales|Company Future Revenue MacroGenics Inc|MGNX - P/S Multiple|Market Cap to Expected Sales Ratio MacroGenics Inc.
Fundamental valuation:MGNX, MacroGenics Inc
Core merchandise of MacroGenics, Inc.

This indicator measures the year-over-year dynamics of earnings per share, reflecting the actual efficiency of capital generation. A positive trend signals growth in profitability, while sharp declines indicate operational disruptions. By analyzing annual EPS growth, an investor assesses the sustainability of the business model. This is critical for MacroGenics, Inc. (MGNX), as partner payments create earnings leverage; however, colossal R&D expenditures often offset this effect.

Main competitors

Earnings per share growth this year OLMA|PBYI (Puma Bio) - Earnings growth in current year|Net earnings per share growth this year Greenwich LifeSciences Inc (GLSI)|Earnings growth in current year ZNTL|PSTV - Earnings per share growth rate in current year|Earnings per share growth in current year Processa Pharmaceuticals, Inc. PCSA|Earnings per share increase in current year EGRX